BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 2, 2005
View Archived Issues
ETB receptor agonist IRL-1620 modifies tumor blood flow
Read More
MAP Pharmaceuticals expands development agreement with Elan
Read More
Fimbrigal P effective in oral candidiasis model
Read More
CX-717 studied in phase IIa trials for Alzheimer's and ADHD
Read More
Phase III lupus management study of CellCept begins dosing
Read More
TargeGen selects TG-100801 for clinical development
Read More
G-CSF demonstrates neuroprotection in stroke models
Read More
IL-24's role in immune regulation
Read More
Expansion of SAINT II study of Cerovive
Read More
Antiinflammatory properties of amentoflavone mediated via inhibition of iNOS
Read More
In vivo evidence of antinociceptive effect of ERK inhibition
Read More
Tsumura and Dainippon return lercanidipine hydrochloride rights to Recordati
Read More
GTC Biotherapeutics and Scancell collaborate on SC-101
Read More
Solvay completes Fournier acquisition
Read More
End-of-phase II meeting for Puricase
Read More
Final results of Novartis' Eon Labs tender offer
Read More
CONFIRM 2 trial of PTK/ZK unlikely to show overall survival benefit
Read More
BLA filed for Myozyme in Pompe disease
Read More
Shorter course of PegIntron and Rebetol receives positive opinion in Europe
Read More
Keppra receives positive opinion in Europe
Read More
Gene therapy combined with transmyocardial revascularization improves myocardial contractility
Read More
Novel therapeutics identified for neurological disorders
Read More
PAI-1 inhibitors in early development at Wyeth for thrombotic disorders
Read More
Novel HMG-CoA reductase inhibitors for lipoprotein disorders emerge from Bristol-Myers Squibb R&D
Read More